Frontiers in Microbiology, 2021 · DOI: 10.3389/fmicb.2020.625862 · Published: January 8, 2021
This study focuses on improving genome editing in Plasmodium falciparum, the parasite that causes malaria, using CRISPR/Cas technology. Researchers developed an improved CRISPR/Cas9 system, named Cas9i, which allows for faster creation of transgenic parasite strains and enables multiplexed genome editing. They also adapted the CRISPR/Cpf1 system, an alternative to Cas9, for use in malaria parasites, expanding the toolkit for gene editing in this pathogen.
The optimized CRISPR/Cas systems will facilitate studies of gene function and molecular mechanisms in P. falciparum.
The ability to perform multiplexed genome editing will aid in understanding the interaction of distinct genes involved in drug resistance.
Improved gene editing tools can contribute to identifying and validating new therapeutic targets for malaria elimination.